ストックスクリーナーアプリを入手
13.97
0.00%
0.00
前日終値:
$13.97
開ける：
$13.97
24時間の取引高:
19.11M
Relative Volume:
5.79
時価総額：
$1.00B
収益：
-
当期純損益:
$-192.96M
株価収益率:
-4.2333
EPS:
-3.3
ネットキャッシュフロー:
$-167.04M
1週間 パフォーマンス:
+0.00%
1か月 パフォーマンス:
-0.14%
6か月 パフォーマンス:
+456.57%
1年 パフォーマンス:
+863.45%
1日の値動き範囲:
$13.96
$14.00
1週間の範囲:
$13.94
$14.00
52週間の値動き範囲:
$0.783
$25.00
Ventyx Biosciences Inc Stock (VTYX) Company Profile
名前
Ventyx Biosciences Inc
セクター
電話
(760) 407-6511
住所
12790 EL CAMINO REAL, SUITE 200, SAN DIEGO
Compare VTYX vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
VTYX
Ventyx Biosciences Inc
|
13.97 | 1.00B | 0 | -192.96M | -167.04M | -3.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
496.83 | 121.97B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
781.67 | 81.49B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
766.92 | 47.74B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
332.92 | 43.93B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
316.99 | 35.67B | 4.98B | 69.60M | 525.67M | 0.5198 |
Ventyx Biosciences Inc Stock (VTYX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-05 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2024-03-12 | アップグレード | Oppenheimer | Perform → Outperform |
| 2024-03-12 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2023-11-07 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2023-11-07 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2023-11-07 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2023-11-07 | ダウングレード | Stifel | Buy → Hold |
| 2023-11-07 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2023-06-14 | 再開されました | Credit Suisse | Outperform |
| 2023-03-21 | 開始されました | Wells Fargo | Overweight |
| 2022-12-19 | 開始されました | Goldman | Buy |
| 2022-11-17 | 開始されました | Morgan Stanley | Overweight |
| 2022-09-07 | 開始されました | Stifel | Buy |
| 2022-09-01 | 開始されました | H.C. Wainwright | Buy |
| 2022-05-09 | 開始されました | Credit Suisse | Outperform |
| 2022-03-31 | 開始されました | Canaccord Genuity | Buy |
| 2022-02-01 | 開始されました | Oppenheimer | Outperform |
| 2021-11-15 | 開始されました | Jefferies | Buy |
| 2021-11-15 | 開始されました | Piper Sandler | Overweight |
すべてを表示
Ventyx Biosciences Inc (VTYX) 最新ニュース
GLAZER CAPITAL, LLC Acquires Significant Stake in Ventyx Biosciences Inc - GuruFocus
Ventyx Faces Eli Lilly Acquisition, Delisting and Litigation - TipRanks
Ventyx Biosciences agrees to $14.00 cash per share merger with Eli Lilly; HSR waiting period cleared - TradingView
242,229 Shares in Ventyx Biosciences, Inc. $VTYX Acquired by GSA Capital Partners LLP - MarketBeat
Monaco Asset Management SAM Sells 536,288 Shares of Ventyx Biosciences, Inc. $VTYX - MarketBeat
Does Ventyx Biosciences Inc. meet Warren Buffett’s criteria2025 Top Gainers & Stock Portfolio Risk Control - mfd.ru
Ventyx Biosciences, Inc. $VTYX Shares Sold by Cibc World Market Inc. - MarketBeat
Ventyx Biosciences (VTYX) to Release Earnings on Thursday - MarketBeat
Growth Value: Is Ventyx Biosciences Inc currently under institutional pressureWeekly Stock Report & Smart Money Movement Tracker - baoquankhu1.vn
Eli Lilly acquires Ventyx Biosciences in $1.2bn deal - Financier Worldwide
Ventyx Biosciences, Inc. (NASDAQ:VTYX) Receives Consensus Recommendation of "Reduce" from Brokerages - MarketBeat
Can Ventyx Biosciences Inc. stock hit record highs againQuarterly Portfolio Summary & Free Community Supported Trade Ideas - mfd.ru
Eli Lilly, Ventyx Biosciences receive early termination from US FTC - MLex
Halper Sadeh LLC is Investigating Whether VAL, STKL, VTYX are Obtaining Fair Deals for their Shareholders - GlobeNewswire
VTYX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Reminds Ventyx Biosciences, Inc. Investors to Join the Class Action Lawsuit! - ACCESS Newswire
Ventyx Biosciences Investor Alert: Kahn Swick & Foti, LLC Investi - The National Law Review
Panic Selling: Does Ventyx Biosciences Inc have a sustainable dividendForecast Cut & Long-Term Growth Portfolio Plans - baoquankhu1.vn
Ventyx Biosciences Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Ventyx Biosciences, Inc.VTYX - Business Wire
Halper Sadeh LLC Encourages STEL, GORO, SKYT, VTYX Shareholders to Contact the Firm to Discuss Their Rights - InsideNoVa.com
SHAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--SKYT, GORO, STEL, and VTYX - Benzinga
Does Ventyx Biosciences Inc offer margin of safetyWeekly Profit Report & High Accuracy Trade Signal Alerts - baoquankhu1.vn
Lilly-Ventyx US premerger waiting period set to expire Feb. 23 - MLex
Ventyx Biosciences Sets March 3, 2026 Vote on Eli Lilly $14-Per-Share Cash Merger - TipRanks
Aug Movers: Is QMCO stock a hidden gemEarnings Performance Report & Stepwise Trade Signal Implementation - baoquankhu1.vn
Chipmakers Recap: Does Ventyx Biosciences Inc meet Warren Buffetts criteriaJuly 2025 Technicals & Growth Focused Entry Reports - baoquankhu1.vn
Short Interest in Ventyx Biosciences, Inc. (NASDAQ:VTYX) Drops By 37.7% - MarketBeat
Will Ventyx Biosciences Inc. benefit from rate cutsEarnings Beat & Daily Price Action Insights - mfd.ru
Halper Sadeh LLC Encourages NATH, VTYX, SKYT Shareholders to Contact the Firm to Discuss Their Rights - marketscreener.com
Assessing Ventyx Biosciences (VTYX) Valuation After Sharp Share Price Momentum And A High P/B Multiple - Yahoo Finance
Ventyx Biosciences (VTYX) Price Target Increased by 12.94% to 13.99 - MSN
Ventyx Biosciences Investor Alert: Kahn Swick & Foti, LLC Invest - GuruFocus
SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger—VTYX, ALEX, RVYL, and FFWM - morningstar.com
Ventyx Biosciences approves cash bonus awards for executives ahead of planned merger - Investing.com Nigeria
Ventyx Biosciences approves cash bonus awards for executives ahead of planned merger By Investing.com - Investing.com South Africa
Ventyx Biosciences Sets Special Cash Bonuses Amid Lilly Merger - TipRanks
Institution Moves: Is Ventyx Biosciences Inc forming a double bottomQuarterly Portfolio Summary & Safe Entry Trade Reports - baoquankhu1.vn
Aug Update: Can Caledonia Mining Corporation Plc be the next market leaderMarket Rally & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
Halper Sadeh Investigates Ventyx and Sun Country Transactions - Intellectia AI
Market Fear: Will Ventyx Biosciences Inc stock hit new highs in YEAR2025 Support & Resistance & Reliable Intraday Trade Plans - baoquankhu1.vn
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Nathan’s Famous, Inc. (Nasdaq – NATH), Lisata Therapeutics, Inc. (Nasdaq – LSTA), Sun Country Airlines Holdings, Inc. (NasdaqSNCY), Ventyx Biosciences, Inc. (Nasdaq - GlobeNewswire Inc.
Ventyx Biosciences, Inc. (NASDAQ:VTYX) Given Average Recommendation of "Reduce" by Analysts - MarketBeat
Published on: 2026-01-21 17:52:30 - baoquankhu1.vn
Does Ventyx Biosciences Inc. stock reflect fundamentalsPortfolio Return Summary & Weekly Top Stock Performers List - bollywoodhelpline.com
Ventyx Biosciences, Inc. (NASDAQ:VTYX) Short Interest Update - MarketBeat
Will Ventyx Biosciences Inc. stock split attract more investorsMarket Sentiment Summary & Entry Point Confirmation Alerts - bollywoodhelpline.com
Eli Lilly Acquires Ventyx Biosciences for $1.2 Billion, Strategizing Beyond Weight Management Drugs - Intellectia AI
Could Acquiring Ventyx Biosciences Send Eli Lilly Stock Soaring in 2026? - Finviz
Halper Sadeh Investigates ON24, Ventyx, and Sun Country for Potential Violations - Intellectia AI
Risk Off: Can RAPT Therapeutics Inc benefit from deglobalizationJuly 2025 Spike Watch & Stepwise Swing Trade Plans - baoquankhu1.vn
Analyst Calls: Will Ventyx Biosciences Inc stock hit new highs in YEARQuarterly Portfolio Summary & Safe Capital Growth Trade Ideas - baoquankhu1.vn
Ventyx Biosciences Inc (VTYX) 財務データ
収益
当期純利益
現金流量
EPS
Ventyx Biosciences Inc (VTYX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Mohan Raju | CEO AND PRESIDENT |
Dec 18 '25 |
Sale |
7.72 |
47,345 |
365,461 |
2,372,863 |
| Nuss John | CHIEF SCIENTIFIC OFFICER |
Dec 17 '25 |
Option Exercise |
0.00 |
34,930 |
0 |
502,156 |
| Nuss John | CHIEF SCIENTIFIC OFFICER |
Dec 18 '25 |
Sale |
7.72 |
12,675 |
97,840 |
489,481 |
1.18%
0.45%
大文字化:
|
ボリューム (24 時間):